ArticleAnalytical chemistry2026
Robust Metabolomics Data Normalization across Scales and Experimental Designs.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolomics studies employing liquid chromatography-mass spectrometry are affected by signal drift and batch effects, introducing technical variance that impedes biological knowledge discovery. Quality control (QC) sample-based normalization strategies are widely implemented but remain vulnerable to outliers, thereby reducing normalization performance. We introduce rLOESS, rGAM, and tGAM, three robust normalization methods that improve resistance to outliers by downweighting or accommodating them. Leveraging additive models, the rGAM and tGAM methods allow flexible nonlinear modeling, differential sample weighting, and data-driven QC representativeness evaluation. Implementations of these methods are gathered in the Metanorm R package, integrating robust normalization with visualization for performance verification while supporting efficient parallel processing. In in silico and/or experimental data sets, the robust methods, relative to several popular existing strategies, improved replicate concordance and reduced drift and batch effects. The robust methods, with improved recovery of the underlying signal demonstrated in simulation, produced distinct differential abundance results, highlighting the impact of normalization on downstream statistical inference. Overall, tGAM-based normalization suggested the best performance across scenarios and is proposed as the default choice. Metanorm is versatile, supporting normalization in metabolomics studies across scales and experimental setups. Metanorm is freely available at https://github.com/UGent-LIMET/Metanorm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.